Introduction
Salmonella-mediated oral DNA vaccination has established itself as a very potent and versatile way of immunization. 1 Although the mechanism of transfer of plasmid DNA into mammalian host cells by attenuated intracellular bacteria is still unclear, the efficient and successful transfer of eukaryotic expression plasmids via attenuated Salmonella has been widely demonstrated. 2, 3 Mucosal application of such bacteria results in the induction of systemic T-cell and humoral responses against antigens encoded by the expression plasmid. Thus far, Salmonella carrying commercially available multicopy expression plasmids based on the pUC replicon conferred protection against various microbial pathogens and tumours in animal models (reviewed by Loessner and Weiss 1 ). The efficacy of these Salmonella vaccines combined with their versatility, ease of preparation and storage, as well as the noninvasive administration by the oral route, renders such vaccines highly suitable for the use in human prophylaxis and therapy as well as for mass vaccination.
Nevertheless, the general applicability of this bacterial carrier system has been hampered by a severe instability of the expression plasmids in the carrier. Plasmid loss and unstable expression of the antigen diminish the efficacy of these recombinant vaccines and could even lead to loss of efficacy. Therefore, the development of appropriate plasmid vector systems for Salmonella-based vaccines in order to enhance the level and duration of antigen expression, and consequently improve the immune response induced is highly desirable.
Several strategies have previously been used to stabilize antigen expression in heterologous systems. Expression from in vivo inducible promoters has been shown to enhance stable expression and immunogenicity of a number of heterologous proteins in Salmonella typhimurium. 4, 5 Chromosomal integration of the expression cassette increased stability but lowered the level of antigen expression to a single copy. 6, 7 Using the asd + / Dasd host lethal system, 8, 9 only Salmonella carrying the expression plasmid can survive. However, the problem of general instability of the expression plasmid has not been systematically addressed to date.
The retention of a plasmid by bacteria during proliferation is influenced by several parameters, for example, the expression level of the heterologous protein, the copy number of the plasmid, its size and complexity. A relationship between plasmid instability and the copy number has previously been observed. 10, 11 High copy number plasmids were rapidly lost from the bacteria whereas a decrease in copy number, thus reducing the plasmid burden, improved plasmid retention in the Salmonella. Since the copy number is regulated by the origin of replication (ori) and partition (par) function of the plasmid, vectors harbouring low copy number replicons consisting of the ori and their respective par region should exhibit improved plasmid stability. Thus, providing for stable vehicles that enable efficacious delivery of antigens or expression plasmids encoding antigens for induction of reproducible and strong immune responses.
In this work, a comparative study between the high copy number plasmid pCMVb and newly constructed low copy number plasmids, carrying the pMB1, 12 p15A 13 or pSC101 14 replicons on the pCMVb backbone was performed. A dramatic increase in plasmid stability in vitro and in vivo was observed for the lower copy number vectors. Oral application of such Salmonella transformants resulted in a superior induction of antigen-specific CD4 + and CD8 + T cells, as well as antibody responses even after a single application. Indeed, mice were partially protected against a high dose of Listeria monocytogenes after a single administration of Salmonella carrying a listeriolysin (LLO) encoding expression plasmid. Following several immunizations, all mice were protected. Application of Salmonella that carried two plasmids with compatible replicons encoding different antigens, resulted in strong humoral and cellular immune responses against both antigens.
Results

Construction of stabilized plasmids
In our original experiments, employing Salmonellamediated oral DNA vaccination, we noted variability in the immune responses induced due to instability of the expression plasmids in the carrier bacteria. 2, 3 The burden of a multicopy plasmid was an obvious reason for such an instability of the vector system. Replacement of the original pUC replicon by low copy number replicons should therefore result in orderly and stable segregation of the plasmids in proliferating bacteria. A series of plasmids were generated based on exchangeable cassettes comprising new replicons in addition to cassettes that encode antibiotic resistance genes for selection and a cassette for antigen expression. As shown in Figure 1a the pUC replicon of the high copy number plasmid pCMVb was exchanged with the low copy replicons pMB1 or p15A and the very low copy number replicon pSC101, resulting in plasmids pCMVbm2A, pCMVbm3A and pCMVbm4A, respectively. To assess the efficacy of the respective vehicle in eliciting protective immunological responses, we additionally incorporated LLO as an antigen into pCMVbm2A generating pCMVhlym2A. Furthermore, the ampicillin resistance gene was replaced by the tetracycline resistance gene in pCMVbm2T and pCMVbm3T in order to examine the potential role of an alternative selection marker.
First, S. typhimurium aroA À were transformed with the above-mentioned expression plasmids and stability was tested in vitro. Transformants were grown in Luria Bertani (LB)-broth with or without appropriate antibiotics for several cycles of overnight cultures. Serial dilutions of each culture were plated on LB-agar or LBagar containing the selective antibiotic in order to estimate the percentage of bacteria still carrying the plasmid. As shown in Figure 1b , the high copy number plasmid pCMVb was rapidly lost under nonselective Stable transformants improve oral DNA vaccines H Bauer et al conditions while the presence of ampicillin resulted in nearly 100% of bacteria containing the plasmid. In contrast, the low copy number plasmids pCMVbm2A and pCMVbm3A as well as pCMVbm4A (Figure 1b ) are stably maintained in the Salmonella even without any selective antibiotics. Low copy number plasmids, where the ampicillin resistance was replaced by tetracycline resistance, were also stably retained in these Salmonella under the same culture conditions (data not shown). Thus, the replacement of the original replicon in the expression plasmid solved the problem of the instability encountered during in vitro culture of the transformants.
An important parameter for the vaccination efficacy is the stability of the vector system in vivo. Therefore, groups of mice received a single oral dose of 1-5 Â 10 8 recombinant bacteria intragastrically and bacterial colonization of murine tissues, as well as the presence of the plasmid in the recovered Salmonella, was analysed for a period of 3 weeks. At different time points, spleen, mesenteric lymph nodes, Peyer's patches and liver were removed and colony forming units (CFU) were determined by plating the homogenized tissues with or without antibiotics. All Salmonella strains were capable of colonizing Peyer's patches, mesenteric lymph nodes, spleen and liver and grew exponentially until day 7-10 after which their numbers decreased. Mesenteric lymph nodes and spleen were colonized at similar rates as compared to Peyer's patches but CFU were 10-to 100-fold lower, respectively. CFU in liver were similar to those observed in spleen (data not shown). Compared to Salmonella carrying the low copy number plasmids, transformants with the high copy number plasmid were detected at three-fold lower numbers in all tissues, although the mice received similar numbers of bacteria.
Plasmid stability of the newly constructed expression vector systems under these in vivo conditions was determined and compared with the multicopy pCMVb. Figure 1c shows that the multicopy plasmid pCMVb was lost within the first 2 days. No Salmonella carrying pCMVb could be detected at the first time point of analysis (day 2). In contrast, plasmids modified with a low copy number replicon were present in all Salmonella throughout the entire observation period (Figure 1c ). Similar results were obtained with pCMVbm2T and pCMVbm3T (data not shown).
Immune responses elicited by oral immunization with stabilized transformants
Although the lower number of copies obviously reduced the metabolic burden of Salmonella and solved the problem of plasmid instability, the need remained to assess whether this also results in sufficient plasmid transfer and antigen expression to stimulate specific cellular and humoral responses. Therefore, the induction of immune responses against the plasmid-encoded antigen b-gal was analysed after oral immunization with the corresponding transformants. Mice received either a single or multiple doses of 1 Â 10 8 S. typhimurium aroA À carrying either pCMVb or the low copy number plasmids or, as negative control, S. typhimurium aroA À without plasmid. At 144 days after the first and 37 days after the fourth immunization, cells from spleen and mesenteric lymph nodes were isolated and tested for proliferation of b-gal-specific CD4 + T cells, as well as antigen-specific IFNg production by CD8 + T cells. Figure 2 shows that the increased stability of Salmonella carrying the low copy number plasmids provoked a strong and antigen-specific CD8 . Four administrations increased the CD8 + and CD4 + T-cell response in mice that received pCMVb-bearing Salmonella considerably, while the responses raised by Salmonella transformants with the different low copy number plasmids were only moderately enhanced (Figure 2b, d) . Obviously, employing the low copy number plasmid recombinants, the maximal strength of the specific response is already obtained using a single administration.
In addition, serum samples were taken from immunized mice killed for cellular assays and analysed for specific antibodies by ELISA. High b-galactosidase (b-gal)-specific antibody titres could be detected in the serum after a single dose of transformants carrying low copy number vectors, whereas pCMVb-bearing Salmonella evoked only a moderate antibody response (Figure 3a) . Several applications of any of the recombinant Salmonella strains could not significantly boost the specific antibody response against b-gal (Figure 3b) . Interestingly, antibody responses induced by the newly established recombinant Salmonella strains were remarkably long-lived. High antibody titres could be detected still 5 months after a single oral dose. This was not observed using the original system.
2,3
Immunization with S. typhimurium aroA À carrying two compatible plasmids
Since the pMB1 and p15A replicons used for construction of the low copy number expression plasmids are compatible in the same bacterium, 15, 16 codelivery of different antigens or antigen and modulating molecules encoded by two plasmids should be possible. Therefore, S. typhimurium aroA À was transformed with the plasmid pCMVhlym2A encoding LLO together with pCMVbm3T encoding b-gal. Transformants carrying both plasmids could be confirmed in the bacterial culture by selection of their respective antibiotic resistance markers.
Groups of mice received, as described above, either a single or multiple doses of the Salmonella harbouring both plasmids, singly transformed Salmonella or an admixture of the two singly transformed bacteria. Strong specific CD4
+ and CD8 + T-cell responses against both antigens were observed regardless of whether dual transformants, the mixture of two strains or singly transformed Salmonella strains were administered (Figure 4) . Comparable results were seen in the antibody titre against b-gal (data not shown).
Protection against lethal doses of L. monocytogenes
Using the virulence factor LLO of L. monocytogenes as an antigen, the generation of protective immunity against a lethal challenge with L. monocytogenes by the doubly transformed Salmonella could be analysed. For comparison, strains carrying single low or high copy number vectors, also encoding LLO, were used. Mice were vaccinated intragastrically with 10 8 Salmonella transformed with the multicopy pCMVhly, low copy pCMVhlym2A or dually transformed with pCMVhlym2A and pCMVbm3T. As a positive control, mice were immunized with a sublethal dose of L. monocytogenes 10 days prior to the challenge. Naïve mice or mice immunized with S. typhimurium aroA À served as unimmunized control. Again, 144 days after the first and 37 days after the last immunization, mice were challenged intravenously with a lethal dose of Listeria corresponding to 10 Â LD 50 , and survival was observed for 2 weeks post-infection. Mice that had received multiple administrations of transformants harbouring an LLO expression plasmid were completely protected, regardless of the copy number or a second compatible expression vector (Figure 5a ). In contrast, a single administration of such transformants could only partially protect mice against this challenge (Figure 5b ), despite the stronger immune response raised in mice immunized with transformants that carried the low copy number plasmids.
Discussion
Bacteria-mediated mucosal DNA vaccination using enterobacteria like Salmonella spp. or Shigella flexneri as carriers, is a novel and highly versatile methodology for serious consideration in general vaccination strategies. ). In addition, in various tumour models, the generation of robust antitumour immune responses either to surrogate or autologous (self) tumour antigens has been demonstrated. 17, 18 Thus, even immunological tolerance might be broken by such regimens.
Nevertheless, the widespread use of this delivery system has probably been hampered by variability in the induction of host immune responses resulting largely from problems related to plasmid stability and hence Stable transformants improve oral DNA vaccines H Bauer et al antigen production. The data presented here now solve a major problem associated with transkingdom DNA transfer and expand on the versatility of the system in incorporating multiple antigens for immunization and therapy.
Plasmids based on pUC replicons result in high copy numbers due to a mutation in the site controlling replication. 19 Consequently, multiple plasmid copies are propagated in laboratory bacteria strains under appropriate selection pressure. However, without selection pressure, especially in bacteria not customized for plasmid propagation like attenuated Salmonella, a rapid loss of plasmids in the carrier bacteria is seen. Therefore, using replicons that fully control replication of the plasmids in proliferating bacteria was a likely solution to the stability problem and turned out to be correct. The newly established expression plasmids that employed the unmodified replicons of three different low copy number plasmids, were stably maintained in the carrier bacteria in vitro in the absence of selective conditions. The successful stabilization of plasmids in Salmonella without the need of stabilizing antibiotics in vitro is especially important for large-scale fermentation.
An additional benefit of these newly designed vectors is the modular assembly that will allow the exchange of essential parts of such plasmids, something already utilized in the present work by exchanging both the antibiotic selection marker and antigen. This will facilitate eventually the introduction of balanced suicide systems 8, 9 where no antibiotic resistance gene is required for plasmid selection any longer, an essential step for human application.
Stable maintenance of the novel low copy number plasmids in the carrier was also demonstrated under nonselective in vivo conditions. In contrast, Salmonella carrying the original high copy number plasmid were rapidly lost. Although it is clear that both immune and protective responses are also generated with the high copy number plasmids, 3 the use of bacterial vehicles harbouring stable replicating and segregating plasmids provide greater reproducibility and potency in generating immune responses. Under such conditions, increased induction of CD4 + and CD8 + T cells as well as prolonged antibody responses could be demonstrated already after a single oral administration of the recombinant Salmonella. Thus, sustained presence of bacteria carrying and presumably transferring low numbers of expression plasmids is superior to a transfer of high numbers of plasmids that can take place only in the initial phase of the oral DNA vaccination. Such stable transformants might simply have a greater chance of targeting immune inductive cells.
The strength of immune responses elicited by these low copy number vectors was independent of whether they were carrying the ampicillin or tetracycline resistance cassette. Interestingly, the tetracycline resistance marker does not contain any CpG motif while the ampicillin exhibits two. 20 Thus, the adjuvant effect of 
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CpG motifs on the expression plasmid appears not to be required under these circumstances. Most likely sufficient adjuvancy is provided by components of the bacterial carrier like endotoxin and CpG containing fragments of the bacterial chromosome. The very low copy number plasmid pCMVbm4A, although inducing a long-lasting antibody response, was weaker in its T-cell inductory strength and resembled more the high copy number vector pCMVb. This suggests that although stability of the transformants is extremely important, there is an optimum regarding the amount of plasmids and/or antigen production for immune response generation. Therefore, to further improve oral DNA vaccination, strategies need to be developed that enhance copy numbers in the host by using amplifiable plasmids or that increase antigen expression in vivo by the introduction of appropriate viral elements.
In protection studies against an overwhelming lethal dose of L. monocytogenes, mice were only partially protected after a single administration of the oral Salmonella-based DNA vaccine using listeriolysin as antigen. This was independent of as to whether high or low copy number plasmids were employed. Multiple applications resulted in complete protection. Thus, despite an increased T-cell response and long-lasting antibody production, induced by transformants with the low copy number vectors, the number and/or quality of memory CD8 + T cells was not sufficient after a single vaccination to confer protection against the applied dose of Listeria. In contrast, a single sublethal amount of L. monocytogenes protected all mice. Although explanations such as the targeting of distinct cell populations could be evoked, the reason for this difference in efficacy is unclear.
Immunization with a single antigen as in the case of Salmonella-mediated DNA vaccination in comparison to immunization with the multiple components of L. monocytogenes might have not raised a sufficient number of T cells upon a single application. On the other hand, memory T cells consist of two subpopulations only one of which remains in an effector state. 21 Thus, the type of memory T cells induced after a single application of the Salmonella-based DNA vaccine might not be of the quality that could handle an exceedingly large dose of Listeria, which, however, can be achieved by repetitive applications. Physiological differences have been demonstrated for memory CD8 + T cells after secondary immunizations compared to CD8 + T cells after primary stimulation. 22 This indicates that the development of protocols is required which influence the physiology of the primary T cells in order to render the memory T cells already fully protective after a single application, for example, by increasing the amount and/or number of antigens as suggested above or by codelivering immune-modulatory molecules like CD40L, IL-15 or IFNb. 23 One potential way of codelivery has been demonstrated in this work. In principle, several ways exist to codeliver immune-modulatory molecules, for instance an internal ribosomal entry site (IRES) could be introduced into the expression construct allowing bi-or multicistronic expression of antigens and modulatory molecules. 24 However, not all combinations of transcripts are supported by IRES elements. Thus, a more straightforward protocol of codelivery might be the use of two independent expression plasmids based on compatible replicons. Although it still needs to be demonstrated that both plasmids introduced by a carrier bacterium are expressed in the same host cell, the data obtained so far are compatible with such an interpretation. Thus, taken together, the newly designed expression vectors employing stabile low copy number replicons have significantly improved the potency and versatility of the Salmonellamediated DNA oral vaccination. Based on such vectors, it should be possible to tackle the urgent problems that presently exist in vaccine development.
Materials and methods
Mice
Female BALB/c (Harlan Winkelmann, Borchem, Germany) mice, 6-8 weeks old, were used throughout the study. All experiments have been performed with the permission of the local boards.
Bacterial strains
Escherichia coli strain TOP10 (Invitrogen, Groningen, The Netherlands) was used for cloning of DNA. The auxotrophic S. typhimurium aroA À strain SL7207 (S. typhimurium 2337-65 derivative hisG46, DEL407 [aroA::Tn10/Tc-s]), kindly provided by Dr BAD Stocker, (Stanford, CA, USA) was used as plasmid carrier for in vitro and in vivo studies. E. coli and S. typhimurium Stable transformants improve oral DNA vaccines H Bauer et al were grown in LB broth or on LB-agar plates at 371C. Ampicillin (Sigma, Taufkirchen, Germany) was added at 100 mg/ml or tetracycline at 50 mg/ml where required. L. monocytogenes strain EGDe 26 was grown in brain-heart infusion (Difco, Detroit, MI, USA) broth at 371C and used for in vivo protection assays.
Construction of eukaryotic expression vectors
For the cloning of the eukaryotic expression plasmids with different replicons and the possibility to exchange the antibiotic resistance and eukaryotic expression cassettes, the eukaryotic expression plasmid pCMVb (Clontech, Palo Alto, CA, USA) was reconstructed to introduce unique restriction enzyme sites. The plasmid was digested with EcoRI and SalI to remove the pUC replicon and the ampicillin resistance gene. 0 into pCMVbm1A after digestion with BglII/SalI. For construction of plasmid pCMVbm4A, PCR amplification of the pSC101 replicon was performed using pWSK29 27 as a template with primers 5 0 -ATAA GAAGATCTTCAGATCCTTCCGTATTTAGCCAGTAT-3 0 and 5 0 -GCGCGCGTCGACGCAGACCCGCCATAAAAC GCCCTG-3 0 and cloned into pCMVbm1A after digestion with BglII/SalI. To exchange the ampicillin cassette with the tetracycline resistance gene to generate pCMVbm2T and pCMVbm3T the TetR gene was PCR amplified with the primer pair 5 0 -GCGCGCACTAGTTCAGGTCGAG GTGGCCCGGCT-3 0 and 5 0 -ATAAGAGAATTCTCATGT TTGACAGCTTATCATCGATAA-3 0 and cloned into the EcoRI and SpeI sites of pCMVbm2A and pCMVb3A, respectively. To generate pCMVhlym2A the hly gene was excised from pCMVhly 2 with NOTI and inserted into pCMVbm2A replacing lacZ.
The heterologous expression of b-gal in the Salmonella carrier was estimated by determining enzymatic activity in the various transformants. 28 For the original transformant bearing the high copy number plasmid 20 MillerUnits could be found while transformants with low copy number expression plasmids showed even less or no activity of b-gal indicating extremely low or no expression in the bacteria. In contrast, expression via a prokaryotic promoter resulted in high enzymatic activity (160 Miller-Units) in the carrier bacteria.
Test of plasmid stability in vitro
All recombinant S. typhimurium strains were cultured in LB-medium containing 1.5% NaCl with and without antibiotics overnight at 371C with slow shaking at 50 r.p.m. until they reached OD 600 0.8. Then an aliquot of the culture was used to set up a new overnight culture at 1:500 dilution. A total of five overnight cultures were carried out. Percentage stability was determined by dividing CFU observed on antibiotic agar plates as indicator for the presence of the plasmid through total CFU observed on LB agar without selecting antibiotics multiplied with 100.
Oral application of Salmonella to mice
Bacteria for animal experiments were cultured overnight as described above in medium containing antibiotics, then washed twice with PBS and resuspended in PBS containing 5% sodium bicarbonate. The bacterial suspension was adjusted to a concentration of 10 9 /ml, corresponding to 10-fold concentrated suspension of OD 600 0.8, and groups of female BALB/c mice were inoculated with 100 ml of the suspension intragastrically using a gavage needle (Acufirm #1428LL, Dreieich, Germany).
Colonization and in vivo plasmid stability
At different time points after oral application of the different recombinant Salmonella strains, Peyer's patches, mesenteric lymph nodes and spleen were removed and colonization was determined as described. 11 Briefly, tissues were homogenized using a Polytron PT 3000 (Kinematica AG, Littau-Lucerne, Switzerland) in 1 ml in PBS containing 0.1% Triton X-100 to lyse the cells and release intracellular Salmonella. Serial dilutions were plated on LB-agar with or without antibiotics to assess bacterial colonization of different organs and to calculate the percent of plasmid stability as described for in vitro stability.
ELISPOT and proliferation assay
Mice received a single or 4 doses of recombinant Salmonella in 4-5 weeks intervals. At 5 weeks after the last or 20 weeks after the first immunization, mice were killed and the induction of CD4 + and CD8 + T cells in spleen and mesenteric lymph nodes were analysed. Lymphocytes were cultured in IMDM (Gibco BRL, Eggenstein, Germany) supplemented with 10% FCS (Integro, Zaandam, The Netherlands), 2 mM L-glutamine, 0.25 mM b-mercaptoethanol (Serva, Heidelberg, Germany), 100 U/ml penicillin and 100 mg/ml streptomycin (Cytogen, Ober-Mö rlen, Germany) at 371C and 5% CO 2 . Induction of specific CD8 + T cells was measured by determinating IFNg secretion after 5 days restimulation with specific peptides (b-Gal 877-885 or LLO 91-99 ) using an ELISPOT assay. Briefly, MAHA plates (Millipore Multiscreen-HA 96-well filtration sterile plates, Millipore, Bredford, MA, USA) were coated with the rat-antimouse IFNg antibody clone R4-6A2 (Pharmingen, San Diego, CA, USA) as capture antibody overnight at 41C. In total, 1 Â 10 5 restimulated lymphocytes per well were incubated with the specific peptide or unspecific control for 24 h undisturbed at 371C and 5% CO 2 in Induction of specific CD4 + T-cell was determined by proliferation using a colorimetric assay based on the cleavage of the tetrazolium salt WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio] benzene disulphonate) to formazan by mitochondrial dehydrogenases in viable cells according to the specification of the supplier (Roche Diagnostics GmBH, Penzberg, Germany). Briefly, 6 Â 10 5 isolated lymphocytes from spleen and mesenteric lymph nodes per well were restimulated in 96-well flat bottom tissue culture plates with 1-10 mg/ml b-gal (Boehringer, Mannheim, Germany) or purified Listeriolysin 29 for 24 h in a humified atmosphere. An amount of 20 ml/well WST-1 was then added and incubated for 4 h at 371C and 5% CO 2 . The production of the formazan dye was quantified by an ELISA reader measuring the absorption at a wavelength of 480 nm.
ELISA
To evaluate the levels of specific antibodies against b-gal or listeriolysin, standard ELISA was employed with serum from mice used for the assays at the same time. Briefly, 96-well-microtitre plates (Maxisorbt Immunoplatten, Nunc, Wiesbaden, Germany) were coated with 0.5 mg/ml purified protein. After incubation of serial dilutions of serum, specific antibodies were detected by peroxidase-conjugated goat-anti-mouse IgG (Dianova, Hamburg, Germany) and OPD (O-phenylenediamine) as substrate.
Challenge
At the time points cellular responses were assessed, 6-9 vaccinated mice per group were also challenged in parallel with 5 Â 10 4 L. monocytogenes (10 Â LD 50 ) and observed for 2 weeks for survival.
